CMS certification 083300
Nemours Children's Hospital, Delaware
1600 Rockland Rd PO Box 269, Wilmington, DE 19899
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $2.7M
- 2020 $3.7M
- 2021 $1.9M
- 2022 $1.7M
- 2023 $1.6M
- 2024 $1.8M
- 2025 $1.5M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $175,499 | 8 |
| Speaking, teaching and other services | $37,555 | 50 |
| Space rental and facility fees | $11,750 | 7 |
| Medical devices and supplies on long-term loan | $7,734 | 3 |
| Education | $5,000 | 1 |
| Charitable contributions | $2,525 | 2 |
| Food and beverage | $300 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | $226,384 | 7 |
| Eli Lilly and Company | $212,279 | 5 |
| Pfizer INC. | $156,127 | 29 |
| Amgen Inc. | $150,678 | 2 |
| Novo Nordisk AS | $147,598 | 41 |
| Abbvie INC. | $124,622 | 3 |
| Global Blood Therapeutics, INC. | $113,647 | 7 |
| KLS-Martin L.P. | $60,000 | 4 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 3, Open-Label, Multicenter, Randomized Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Ado… Amgen Inc. | $150,678 |
| B19-061 Ph 3 Pediatric Study of venetoclax and chemotherapy ABBVIE INC. | $123,872 |
| EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY VERSUS PLACEBO FOR THE TREATMENT OF OBESITY AND WEIGHT-RELATED COMORBIDITIES IN ADOLESCENTS: A RANDOMI… Eli Lilly and Company · NCT06439277 | $121,421 |
| AN OPEN LABEL OBSERVATIONAL PROSPECTIVE REGISTRY OF PARTICIPANTS WITH SICKLE CELL DISEASE SCD TREATED WITH OXBRYTA VOXELOTOR GLOBAL BLOOD THERAPEUTICS, INC. | $113,647 |
| A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis VERTEX PHARMACEUTICALS INCORPORATED | $104,622 |
| A Non-Interventional Study Evaluating the Impact of TRIKAFTA Initiation on 2- to 5-Year-Olds With Cystic Fibrosis and Their Caregivers in a Real-Worl… VERTEX PHARMACEUTICALS INCORPORATED | $86,865 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH AN OPEN-LABEL EXTENSION ASSESSING THE EFFICACY, SAFETY, AND PHARMACOKINETICS PHARM… Eli Lilly and Company · NCT05260021 | $63,891 |
| NN9924-4437 Novo Nordisk AS | $58,061 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Nemours Children's Hospital, Delaware
Does Nemours Children's Hospital, Delaware have an emergency room?
Yes. CMS lists emergency services at Nemours Children's Hospital, Delaware.
Does Nemours Children's Hospital, Delaware receive money from drug and device companies?
Drug and device makers reported $1.5M in payments to Nemours Children's Hospital, Delaware for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.